LATEST NEWS IN PROSTATE CANCER
Interpreting a Pathology Report: 15 Biopsy and Gleason Questions Answered by a Leading Pathologist
Interpreting a Pathology Report By Jonathan Epstein, MD | Johns Hopkins University
Patients should personally review their pathology report; the expert description of the information obtained from the needle biopsy. In this article, Dr. Epstein answers 15 common questions about understanding a pathology report.
Prostate Biopsy and Alternatives
It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer and about half of these with Low-Risk disease, a condition that can be safely monitored without immediate treatment. Even so, more than half of these men with Low-Risk will undergo prompt, radical treatment. Sadly, irrational fears rooted in the electrifying word “cancer” drive most men into taking immediate action.
New Approach To Prostate Cancer Screening
Why Screen for Prostate Cancer?
Screening finds earlier stage cancers, allows for simpler treatments with fewer side effects, and saves lives. For example, in 1985, prior to PSA screening, the prostate cancer five-year survival rate was 69% compared to 99% in 2006. It’s unclear whether this dramatic survival increase is entirely due to PSA screening. Other factors, such as improved therapy have also contributed.